Loading...
Loading...
Mediware® Information Systems, Inc.
MEDW today announced that it has acquired substantially all the assets of St. Louis-based Transtem, LLC, a provider of software that manages the collection and transplantation of adult stem cells in cellular-based therapies and medical research.
The acquisition continues the expansion of Mediware's blood management expertise and extends the company with software and domain expertise in a rapidly growing field that includes cancer treatment and regenerative medicine. Details related to the acquisition were not released.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in